Enzymology of Chlamydial Pathogenesis

衣原体发病机制的酶学

• 批准号: 8697935
• 负责人: Dewey G McCafferty
• 金额: $ 23.53万
• 依托单位: DUKE UNIVERSITY
• 依托单位国家: 美国
• 财政年份: 2014
• 资助国家: 美国
• 起止时间: 2014-03-15 至 2019-02-28
• 项目状态: 已结题
• 来源: https://reporter.nih.gov/project-details/8697935
• 关键词: Actins; Acute; Affect; Animal Model; Animals; Apoptosis; Bacteria; Bacterial Infections; Benchmarking; Biochemical; Biological Factors; Biology; Blindness; Caspase-1; Cell Culture Techniques; Cell Death; Cell model; Cell physiology; Cells; Cellular Morphology; Chemicals; Chlamydia; Chlamydia Infections; Chlamydia trachomatis; Chronic; Cytoskeleton; Cytosol; Data; Defect; Detection; Development; Disease; Drug Formulations; Drug Kinetics; Ectopic Pregnancy; Effectiveness; Endothelial Cells; Enzymatic Biochemistry; Enzymes; Epitopes; Figs - dietary; Genital system; Goals; Growth; Health; Hela Cells; Host Defense; Housing; Human; Immune; Immunity; Immunologic Markers; In Vitro; Infection; Infection prevention; Infertility; Inflammation; Inflammatory; Intermediate Filaments; Knock-out; Life; MEKs; Mass Spectrum Analysis; Mediating; Methods; Microtubules; Modeling; Molecular; Motor; Mus; Pathogenesis; Pathology; Pathway interactions; Pelvic Inflammatory Disease; Pelvis; Peptide Hydrolases; Peptide Library; Persons; Proteins; Proteolysis; Proteome; Publishing; Recombinants; Refractory; Research Project Grants; Role; S Phase; Scanning; Serine Protease; Serum; Signal Pathway; Signal Transduction; Small Interfering RNA; Solid; Specificity; Structure; Trachoma; Transmembrane Transport; Treatment Protocols; Vaccines; Vacuole; Virulence Factors; Woman; acquired immunity; adaptive immunity; analog; antimicrobial; base; chemical genetics; clinically relevant; cytokine; defense response; design; factor C; genetic manipulation; in vivo; inhibitor/antagonist; insight; killings; lipid transport; men; multicatalytic endopeptidase complex; mutant; overexpression; pathogen; programs; public health relevance; response; restoration; salinosporamide A; scaffold; small molecule; tandem mass spectrometry

DESCRIPTION (provided by applicant): Despite aggressive antimicrobial treatment regimens, over 100 million persons are infected annually worldwide with the sexually-transmitted obligate intracellular bacterial pathogen, Chlamydia trachomatis. During infection, C. trachomatis secretes effector proteins into the host cytosol that interfere with host signaling networks to dampen host immune defenses. Unfortunately infections are asymptomatic in the majority of men and women, development of long-term protective immunity against reinfection is inhibited, and therefore many infections become chronic and spur secondary pathologies like infectious blindness (trachoma), pelvic inflammatory disorder, ectopic pregnancy, and infertility. The serine protease chlamydial protease-like activity factor (CPAF) has emerged as a central chlamydial virulence factor due to its importance in lipid and membrane transport, actin cytoskeleton structure and dynamics, microtubule-based motors, lysosomal recognition of the inclusion, ERK/MEK signaling pathways, and the onset of programmed cell death and inflammation signaling. Using an inhibitor-based chemical biology approach, we recently developed two classes of CPAF inhibitors, and observed that inhibition of CPAF activity inhibited bacterial replication, destabilized the integrity of the parasitophorous inclusion vacuole housing replicating chlamydia, and resulted in bacterial cell death. We also determined that CPAF inhibition reprogrammed infected cells to re-initiate host immune defense responses to infection by secreting pro-inflammatory cytokines and activating an inflammasome-dependent programmed host cell death pathway. Based on these collective data, we hypothesize that CPAF inhibitors may form the basis for a new class of small molecule 'antimicrobial vaccines' that not only kill bacteria, but also may enhance adaptive and acquired immunity responses to chlamydial infections. Our goals for this proposal are to understand the role CPAF in C. trachomatis pathogenesis, to gain insight into the molecular level details of CPAF protease function, inhibition and identification of targets, and to determine the extent to which CPAF inhibitors can clear infections, rescue host immune defense activity, and protect against reinfection in a clinically relevant murine animal model of chlamydial genital tract infection.

描述（由申请人提供）：尽管有积极的抗菌治疗方案，但全球每年仍有超过1亿人感染性传播的专性细胞内细菌病原体沙眼衣原体。在感染过程中，C.沙眼衣原体分泌效应蛋白到宿主细胞质中，干扰宿主信号网络以抑制宿主免疫防御。不幸的是，在大多数男性和女性中，感染是无症状的，针对再感染的长期保护性免疫力的发展受到抑制，因此许多感染变成慢性并引发继发性病理，如传染性失明（沙眼），盆腔炎性疾病，异位妊娠和不孕症。丝氨酸蛋白酶衣原体蛋白酶样活性因子（CPAF）由于其在脂质和膜转运、肌动蛋白细胞骨架结构和动力学、基于微管的马达、包涵体的溶酶体识别、ERK/MEK信号传导途径以及程序性细胞死亡和炎症信号传导的发生中的重要性而成为中心衣原体毒力因子。使用基于通道的化学生物学方法，我们最近开发了两类CPAF抑制剂，并观察到抑制CPAF活性抑制细菌复制，破坏寄生虫包涵体空泡房屋复制衣原体的完整性，并导致细菌细胞死亡。我们还确定，CPAF抑制重编程感染的细胞，以重新启动宿主免疫防御反应的感染，分泌促炎细胞因子和激活炎性小体依赖性程序性宿主细胞死亡途径。基于这些收集的数据，我们假设CPAF抑制剂可能形成一类新的小分子“抗菌疫苗”的基础，不仅杀死细菌，而且可能增强对衣原体感染的适应性和获得性免疫反应。我们这个提案的目标是了解CPAF在C中的作用。本发明的目的在于研究沙眼衣原体的发病机制，以深入了解CPAF蛋白酶功能的分子水平细节、靶标的抑制和鉴定，并确定CPAF抑制剂可以在衣原体生殖道感染的临床相关鼠动物模型中清除感染、拯救宿主免疫防御活性和防止再感染的程度。